Fact-checked by Grok 2 weeks ago

Parotitis

Parotitis is the inflammation of one or both parotid glands, the largest of the major salivary glands located anterior to the ears and inferior to the external auditory canal, and it represents the most common inflammatory condition affecting these glands. It manifests as painful swelling of the affected gland(s), often accompanied by tenderness, fever, and reduced salivary flow, and can be classified as acute or chronic based on duration and recurrence. While generally self-limiting in viral cases, untreated bacterial parotitis can lead to serious complications such as formation or . The etiology of parotitis is diverse, encompassing infectious, obstructive, and systemic causes. Acute parotitis is most frequently viral, with mumps (caused by the paramyxovirus) being the classic example, accounting for over 70% of symptomatic infections and presenting with bilateral glandular swelling in many cases. Bacterial parotitis, typically suppurative and unilateral, is commonly due to Staphylococcus aureus or oral flora, often precipitated by dehydration, poor oral hygiene, sialolithiasis (salivary stones obstructing ducts), or immunosuppression in hospitalized elderly patients, with an incidence of 0.01% to 0.02% in this population. Chronic parotitis may arise from recurrent infections, autoimmune disorders like Sjögren's syndrome, radiation therapy, or rarely, underlying malignancies, with 80% to 85% of salivary gland tumors occurring in the parotid and 75% of these being benign. Epidemiologically, the incidence of parotitis has declined significantly due to widespread vaccination against mumps; in the United States, reported mumps cases fell from over 6,000 annually in the mid-2010s to fewer than 500 per year by 2021, and have remained low since, with 226 cases reported as of September 2025. Acute bacterial forms are more prevalent in postoperative or debilitated individuals, while chronic recurrent non-suppurative parotitis affects children and adults without a clear gender predominance. Globally, viral parotitis remains a concern in unvaccinated populations, particularly in outbreak settings. Diagnosis relies on clinical history and , revealing tender, erythematous swelling over the parotid region, sometimes with purulent discharge from Stensen's duct. Imaging modalities such as (first-line for its non-invasiveness) or scans help identify abscesses, stones, or masses, while laboratory tests including cultures, viral serology for , or autoantibodies for autoimmune etiologies confirm the cause. Treatment varies by etiology but emphasizes supportive care and addressing the underlying cause. Viral parotitis, such as , is managed symptomatically with , analgesics, warm compresses, and rest, typically resolving in 5 to 10 days. Bacterial cases require intravenous antibiotics (e.g., anti-staphylococcal agents), sialagogues to promote flow, and for abscesses; or refractory cases may necessitate sialendoscopy or . is favorable with early , though complications like injury, sialadenitis, or, in , orchitis and , underscore the need for prompt medical attention.

Overview

Definition

Parotitis refers to the inflammation of one or both s, which are the largest of the major salivary glands located anterior and inferior to the ears, on the sides of the face between the ear and jaw. These glands are responsible for producing primarily serous saliva, a watery secretion that aids in and oral . The is an irregularly shaped, lobulated structure enveloped by a thin capsule and divided into superficial and deep lobes by the branches of the , which courses through the gland without innervating it directly but providing motor innervation to the muscles of . The main excretory duct of the parotid gland, known as Stensen's duct or the parotid duct, arises from the anterior border of the gland, travels across the masseter muscle, and opens into the oral cavity opposite the upper second molar tooth, facilitating the drainage of saliva. This anatomical arrangement makes the gland susceptible to inflammatory processes that can obstruct ductal flow or involve surrounding structures. Parotitis is classified into acute and chronic forms based on its onset, duration, and characteristics. Acute parotitis typically presents with sudden onset and is often suppurative, involving pus formation due to bacterial infection. In contrast, chronic parotitis is recurrent or persistent and frequently non-suppurative, associated with autoimmune or recurrent inflammatory changes without abscess formation. The term "parotitis" derives from the Greek words "para-" meaning "beside" and "otis" meaning "ear," reflecting the gland's position adjacent to the ear, with its earliest recorded use in English medical literature dating to the late 1700s.

Epidemiology

Parotitis represents the most common inflammatory condition of the major salivary glands, comprising a substantial portion of salivary gland disorders worldwide. Acute bacterial parotitis, in particular, has an incidence of 0.01% to 0.02% among hospitalized older adults and 0.002% to 0.04% in postoperative patients. Globally, viral parotitis due to mumps has seen a decline, with an average of about 500,000 cases reported annually to the World Health Organization from 1999 to 2019, though incidence remains higher in unvaccinated populations; reported cases continued to decrease, reaching 245,032 in 2024. Demographically, acute parotitis disproportionately affects neonates under 1 year, elderly individuals over 60 years due to age-related physiological changes such as reduced salivary flow, and postoperative patients. Mumps-related parotitis is more prevalent in unvaccinated children under 15 years, particularly those aged 2 to 9 in or college settings. Chronic parotitis tends to occur in adults aged 40 to 60, with juvenile recurrent parotitis showing highest incidence in Black males aged 2 to 8. Key risk factors include , poor , from conditions like or treatments such as , and ductal obstruction. , a common obstructive cause, has an estimated incidence of 28 to 59 cases per million per year in the general population. , international travel, and crowded living conditions further elevate risk. Geographically, mumps incidence is elevated in developing regions with MMR coverage below 90%, where outbreaks occur approximately every 5 years in unvaccinated communities; global first-dose measles (proxy for MMR) coverage stood at 83% in 2023 and increased to 84% in , with lower rates in low- and middle-income countries. Trends indicate a continued decline in viral parotitis attributable to vaccination programs, contrasted by a rise in bacterial cases among aging populations in high-income settings due to increased elderly demographics and use that impairs salivary .

Signs and Symptoms

Acute Parotitis

Acute parotitis is characterized by the sudden onset of unilateral or bilateral swelling over the parotid region, often accompanied by severe pain and tenderness that intensifies during mastication. Patients typically experience fever and chills, with overlying of the skin contributing to the inflammatory appearance. In bacterial cases, purulent discharge may be expressed from Stensen's duct, often presenting with a foul in the . Systemic manifestations include leukocytosis indicative of infection, alongside signs of dehydration such as dry mouth and reduced salivary flow. Trismus, or jaw stiffness, can occur due to the proximity of the inflamed gland to masticatory muscles, complicating oral intake. These effects are more pronounced in vulnerable populations, such as the elderly or debilitated individuals. The condition typically develops over hours to days. Progression may lead to abscess formation within the gland or systemic sepsis, particularly in cases of bacterial involvement. Unlike chronic parotitis, which involves recurrent and less acutely painful episodes, acute parotitis demands prompt to prevent complications.

Chronic Parotitis

Chronic parotitis is characterized by recurrent or persistent of the , often presenting with an insidious onset and episodes that recur over months to years, distinguishing it from the more abrupt and suppurative nature of acute parotitis. This form typically involves milder glandular involvement without prominent systemic features, focusing instead on ongoing low-grade changes in function. Primary symptoms include intermittent unilateral or bilateral swelling of the , accompanied by mild discomfort that is generally less severe than in acute episodes. Episodes often occur around mealtimes. , or dry mouth resulting from reduced salivary flow, is a common feature. These swellings may cause facial fullness and tenderness, with episodes persisting for days to weeks before subsiding. In cases associated with autoimmune disorders like Sjögren's syndrome, additional signs such as fatigue and may emerge due to systemic involvement. Foul breath can arise from secondary bacterial infections, particularly if purulent material accumulates in the ducts. Long-term complications encompass an elevated risk of salivary gland tumors, including (MALT) lymphoma, particularly after years of chronic inflammation in autoimmune contexts. Chronic parotitis is more prevalent among middle-aged women, with peak incidence in those aged 40 to 60 years and a slight female predominance overall.

Causes

Infectious Causes

Infectious causes of parotitis primarily involve bacterial, viral, and less commonly fungal or mycobacterial pathogens, leading to acute or of the through microbial invasion and suppuration. Bacterial infections are the most frequent in acute suppurative parotitis, particularly in dehydrated or elderly patients where reduced salivary flow promotes retrograde ascent of oral flora through Stensen's duct. predominates, accounting for 50% to 90% of cultured cases, followed by species and anaerobic bacteria such as Peptostreptococcus and . This mechanism is facilitated by risk factors including poor , , and conditions causing salivary stasis, resulting in glandular suppuration and potential formation. In elderly individuals, bacterial parotitis represents a rising proportion of acute cases due to age-related hyposalivation and with medications. Viral infections typically cause acute, often self-limiting parotitis via or lymphatic spread, with (a paramyxovirus) being the classic example, presenting as bilateral glandular swelling in approximately 70% of cases. Other viruses include influenza A and parainfluenza, , Epstein-Barr virus, and enteroviruses like , which enter through the respiratory tract and disseminate hematogenously to the salivary glands. Human immunodeficiency virus () can lead to chronic parotitis through persistent viral replication in immunocompromised hosts. The introduction of the mumps vaccine in has reduced U.S. incidence by over 99%, though outbreaks persist in under-vaccinated populations. Fungal pathogens, such as species (particularly C. albicans and C. glabrata), rarely cause parotitis but occur in immunocompromised patients via ascending ductal or hematogenous dissemination, often in the context of prolonged use or . Mycobacterial infections are uncommon and include in endemic areas, typically via hematogenous spread or ascending coexisting with pulmonary disease in up to 25% of cases, and nontuberculous mycobacteria (e.g., M. avium complex) ascending via Stensen's duct in susceptible individuals.

Non-Infectious Causes

Non-infectious causes of parotitis encompass a range of mechanical, autoimmune, metabolic, and iatrogenic factors that lead to of the without microbial involvement. These etiologies often result from obstruction of salivary flow, immune-mediated damage, or reduced glandular function, promoting and subsequent sterile . Unlike infectious forms, they may present as acute, recurrent, or chronic swelling, frequently bilateral in systemic conditions. Obstructive causes, particularly , involve the formation of calcified stones within the parotid ducts or gland, leading to blockage and glandular distension. Although 80-90% of salivary stones occur in the , approximately 6-20% affect the parotid, often causing intermittent painful swelling exacerbated by meals due to increased salivary demand. This obstruction creates salivary , which can precipitate and, in some cases, secondary bacterial overgrowth, though the primary mechanism is mechanical. Pathophysiologically, stones form from and carbonate deposits around a nidus of desquamated cells or mucus in stagnant . Autoimmune and systemic disorders frequently underlie chronic or recurrent parotitis through lymphocytic infiltration and glandular destruction. Sjögren's syndrome, an autoimmune condition targeting exocrine glands, causes bilateral parotid enlargement in up to 30-60% of cases via T-cell mediated inflammation and fibrosis, resulting in and recurrent swelling. Sarcoidosis may present with granulomatous involvement of the parotid, mimicking chronic . Metabolic factors like uncontrolled contribute through and sialosis, leading to painless hypertrophy, while can cause sialadenosis, leading to painless bilateral parotid enlargement due to recurrent vomiting-induced glandular hyperactivity and nutritional deficiencies. Iatrogenic and dehydration-related causes arise from interventions or physiological states that impair salivary . to the head and neck, such as for malignancies, can induce transient acute parotitis due to inflammatory , occurring in approximately 5% of patients shortly after initial treatments and long-term from acinar and . Medications like anticholinergics (e.g., atropine) or diuretics reduce flow by inhibiting glandular , while prolonged nil per os () status during surgery or in critically ill patients leads to viscous and ductal . These factors collectively diminish parotid and , fostering inflammation. Other non-infectious triggers include , which can cause direct glandular injury or leading to swelling, as seen post-surgical manipulation like . may mimic parotitis with unilateral swelling but lacks true . Juvenile recurrent parotitis of childhood (JRPC), often idiopathic, affects children aged 2-8 years with episodes of unilateral or bilateral swelling, potentially linked to ductal anomalies or immune dysregulation, though its exact remains unclear and involves recurrent sterile resolving by in most cases. Overall, non-infectious parotitis centers on salivary from obstruction or hypofunction, triggering innate immune responses, or autoimmune T-cell infiltration causing acinar damage without .

Diagnosis

Clinical Assessment

The clinical assessment of parotitis begins with a detailed history to characterize the presentation and identify potential etiologies. Clinicians inquire about the onset of symptoms, distinguishing acute cases, which often present with sudden unilateral swelling and pain, from chronic or recurrent episodes that may involve intermittent enlargement triggered by meals or dehydration. Associated symptoms such as fever, chills, malaise, dry mouth (xerostomia), or difficulty chewing are elicited, along with risk factors including recent dehydration, immunosuppression (e.g., from diabetes, HIV, or chemotherapy), poor oral hygiene, and vaccination status, particularly for mumps in unvaccinated individuals. Physical examination focuses on the parotid region to confirm glandular involvement and assess severity. The , normally soft, smooth, and non-palpable, is palpated for tenderness, warmth, and swelling that may obscure the angle of the ; bimanual palpation of the gland and Stensen's duct is performed to evaluate for induration or masses. Gentle compression over the gland may express or cloudy from the papilla of Stensen's duct in infectious cases, while lymph nodes in the preauricular, submandibular, and cervical regions are examined for enlargement or tenderness. overlying the skin or foul-tasting discharge further supports an inflammatory process. Differential diagnosis considers conditions mimicking parotid swelling, such as (often with odontogenic pain and intraoral findings), (presenting as painless, firm enlargement), of submandibular or sublingual glands, masseter hypertrophy (causing firm, non-tender prominence without ductal involvement), and (a rapidly spreading floor-of-mouth with bilateral swelling and ). Red flags warranting urgent evaluation include (indicating possible or severe infection), severe suggesting underlying , and signs of systemic compromise such as high fever or respiratory distress.

Diagnostic Tests

Laboratory tests play a crucial role in evaluating parotitis by identifying signs of infection or inflammation and guiding etiological diagnosis. A () often reveals with in cases of bacterial parotitis, indicating an acute infectious process. Inflammatory markers such as () and () are typically elevated, reflecting the degree of , though they lack specificity for parotitis alone. For suspected bacterial causes, and culture of expressed from Stensen's duct or obtained via provide essential information on the causative and susceptibility, with being the most common isolate. Viral etiologies, particularly , are confirmed through real-time () on buccal swabs or , which is the preferred method due to its higher compared to IgM , especially when samples are collected within 3 days of parotitis onset. In cases of unilateral cystic enlargement or risk factors, testing via antigen/antibody immunoassay is recommended to rule out associated parotitis. Imaging modalities are essential for visualizing parotid gland abnormalities, detecting complications, and differentiating causes. Ultrasound serves as the first-line imaging test, offering high-resolution assessment of glandular enlargement, abscesses, calculi, and ductal dilation with approximately 90% sensitivity for detecting stones greater than 2 mm; it is particularly preferred in children to avoid exposure. For more complex evaluations, such as suspected deep abscesses, fistulas, or neoplasms, contrast-enhanced computed () provides detailed anatomical information on gland size, shape, and surrounding structures, though it involves and is used judiciously in . (), often with enhancement, excels in soft tissue characterization and is indicated for chronic cases or suspected tumors, while magnetic resonance sialography non-invasively delineates ductal abnormalities without contrast injection. Conventional sialography, involving contrast injection into the ductal system, is reserved for chronic parotitis to identify strictures or obstructions but has largely been supplanted by MRI due to its invasiveness. Procedural interventions aid in definitive when is inconclusive. (FNA) allows for cytological examination, culture, and sensitivity testing in suspected bacterial abscesses, (via Ziehl-Neelsen stain or ), or , providing targeted material for analysis. In chronic or recurrent parotitis, salivary using pertechnetate assesses glandular function and uptake/ dynamics, helping differentiate obstructive from inflammatory pathologies, particularly in conditions like Sjögren's syndrome. These tests collectively confirm parotitis and its etiology, enabling tailored management.

Management and Treatment

Supportive Measures

Supportive measures for parotitis focus on alleviating symptoms, promoting salivary flow, and preventing complications across all cases, regardless of . Adequate is essential to maintain function and reduce stasis, with oral fluids encouraged for most patients; intravenous fluids are recommended for those with , particularly in severe or suppurative presentations. To stimulate saliva production and relieve dryness, sialogogues such as sugarless gum, drops, or swabs can be used, alongside mouth rinses for to minimize the risk of secondary bacterial infections. Pain and swelling are managed with analgesics like nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen, and application of warm compresses to the affected area, often combined with gentle to promote . Dietary modifications include consuming soft, easy-to-swallow foods to minimize discomfort during mastication, while avoiding irritants such as acidic or spicy items that could exacerbate . In cases of severe swelling, close monitoring for airway compromise is necessary, as significant may threaten respiratory function. Hospitalization is advised for vulnerable populations, including the elderly and immunocompromised individuals, to facilitate close observation and support if needed. Patients should be monitored for signs of formation, such as persistent fever beyond 48 hours despite initial therapy, which may warrant further intervention. For bacterial cases, supportive measures are often combined with targeted antibiotics, as detailed in cause-specific interventions.

Cause-Specific Interventions

For infectious causes of parotitis, targets the specific identified through or clinical suspicion. Bacterial parotitis, often due to or anaerobic bacteria, is managed with intravenous antibiotics such as amoxicillin-clavulanate or clindamycin for 7-14 days, with a reported cure rate of approximately 80% when combined with hydration. Viral parotitis, such as , is typically supportive only and resolves within 7-10 days without specific antiviral therapy. Antivirals like acyclovir are rarely used but may be considered for virus-associated cases. If an forms, ultrasound-guided needle aspiration or and is performed alongside antibiotics to prevent complications. In obstructive parotitis, interventions focus on relieving ductal blockage from sialoliths or cysts. Sialendoscopy enables minimally invasive visualization and removal of stones from the , often with or for stones up to 8 mm. For ranula-like parotid cysts, intraoral creates an open drainage pathway while preserving gland function. Small stones may pass spontaneously with increased hydration and sialogogues, as referenced in supportive measures. Autoimmune-related parotitis, commonly associated with Sjögren's syndrome, requires to reduce glandular . Corticosteroids like are used for acute flares, providing rapid symptom relief in severe cases. For refractory glandular swelling, rituximab infusions target B-cell hyperactivity, showing efficacy in reducing parotid enlargement. , a frequent sequela, is alleviated with to stimulate production. For chronic or recurrent parotitis unresponsive to conservative approaches, superficial or total is considered in refractory cases, with required in a minority of patients after failed sialendoscopy or medical therapy. is generally avoided due to risks of permanent and secondary malignancies.

Prevention

Vaccination Strategies

The measles-mumps-rubella (MMR) is the primary immunization strategy for preventing parotitis caused by , a common viral of the condition. The standard regimen consists of two doses: the first administered at 12-15 months of age and the second at 4-6 years of age. This schedule provides 88% efficacy against after two doses, significantly reducing the incidence of mumps-associated parotitis. Outbreaks of mumps parotitis continue to occur disproportionately among unvaccinated adults, highlighting the need for high population-level immunity. In addition to MMR, the annual can help mitigate rare cases of parotitis linked to , particularly H3N2 strains, by preventing underlying respiratory infections that may complicate into inflammation. For adults lacking prior , catch-up dosing with MMR is recommended, especially for high-risk groups such as healthcare workers, to ensure at least two doses and bolster protection against transmission in clinical settings. Globally, the (WHO) endorses achieving at least 95% coverage with two doses of in national programs to interrupt transmission and prevent parotitis outbreaks. Despite vaccination, outbreaks can occur due to waning vaccine-induced immunity over time, underscoring the importance of maintaining robust vaccination rates. For special populations, a third dose of MMR may be considered as a booster during outbreaks for those with two prior doses, though severely immunocompromised individuals are generally contraindicated for live like MMR due to risks of vaccine-derived ; alternative strategies, such as , are prioritized instead. Unlike viral causes, bacterial parotitis lacks a specific , necessitating focus on other preventive measures for those etiologies.

Risk Reduction Practices

Maintaining good is essential for preventing parotitis, particularly non-infectious forms caused by salivary or ductal obstruction, as adequate fluid intake promotes salivary flow and reduces the risk of gland swelling. can lead to thickened , increasing susceptibility to bacterial infections or stone formation in the parotid ducts. Individuals at higher risk, such as those with reduced salivary production due to medications or medical conditions, should aim for at least 2-3 liters of water daily unless contraindicated. Practicing rigorous significantly lowers the incidence of bacterial parotitis by minimizing oral bacterial load and preventing dental issues that could obstruct salivary ducts. This includes regular brushing, flossing, and professional dental cleanings to avoid plaque buildup or caries that might contribute to ascending infections. For those prone to , chewing sugar-free gum or using sialogogues like lemon drops can stimulate saliva production, further reducing stagnation. Frequent handwashing and avoiding close contact with infected individuals are key measures to curb the spread of viral parotitis, such as , by interrupting transmission through respiratory droplets or . The CDC recommends washing hands with for at least 20 seconds, especially after touching the face or shared surfaces, and using alcohol-based sanitizers when is unavailable. In outbreak settings, self-isolation for five days after symptom onset helps contain spread, though this applies more to case management than primary prevention. Managing underlying health conditions plays a crucial role in risk reduction, as uncontrolled or autoimmune disorders like Sjögren's syndrome can impair salivary function and heighten parotitis vulnerability. Regular monitoring and treatment of these conditions, including glycemic control in diabetics, can mitigate this risk. Additionally, avoiding and excessive consumption prevents mucosal irritation and that exacerbate inflammation. Ensuring balanced nutrition supports immune function, indirectly reducing infection susceptibility. Patients on drugs, which decrease salivation, should consult providers for alternatives or adjunctive therapies to maintain flow.

References

  1. [1]
    Parotitis - StatPearls - NCBI Bookshelf - NIH
    Jun 23, 2025 · Parotitis, or inflammation of the parotid glands, is the most common inflammatory condition affecting the major salivary glands.Etiology · History and Physical · Treatment / Management · Differential Diagnosis
  2. [2]
    Salivary gland infections: MedlinePlus Medical Encyclopedia
    ### Summary of Salivary Gland Infections (Focusing on Parotitis)
  3. [3]
    Mumps - StatPearls - NCBI Bookshelf
    May 1, 2024 · Mumps parotitis is the most common manifestation of the virus, occurring in over 70% of infections. Parotid swelling is typically bilateral, but ...<|control11|><|separator|>
  4. [4]
    Clinical Overview of Mumps - CDC
    Jan 17, 2025 · Common clinical features include parotitis (swollen salivary glands in cheek and jaw area) and fever. Mumps spreads through direct contact ...Key Points · Clinical Features · Diagnosis And Laboratory...
  5. [5]
    Clinical Features of Mumps - CDC
    Jun 5, 2024 · Parotitis usually lasts on average 5 days and most cases resolve after 10 days. Mumps infection is most often confused with swelling of the ...
  6. [6]
    Parotitis: Parotid Gland Swelling Causes, Symptoms & Treatment
    “Parotitis” is the medical term for a swollen parotid gland. Your parotid glands are located on the side of your face, between your ear and your jaw.
  7. [7]
    Anatomy, Head and Neck, Parotid Gland - StatPearls - NCBI Bookshelf
    Sep 10, 2024 · The parotid main excretory duct (Stensen duct) projects from ... The facial nerve courses through the parotid gland, providing motor ...Introduction · Structure and Function · Blood Supply and Lymphatics · Nerves
  8. [8]
  9. [9]
    Parotid gland: Anatomy, innervation and clinical aspects - Kenhub
    Parotid duct (Stensen Duct)​​ Two major ducts arising from the parotid gland unite within the substance of the organ to form the parotid duct of Stensen . The ...
  10. [10]
    Parotitis: Practice Essentials, Background, Pathophysiology
    Aug 13, 2024 · When surgery is required for chronic parotitis, the standard treatment is superficial parotidectomy, but if CT scanning or surgery reveals ...
  11. [11]
    Parotitis overview: an integrated approach from classification to ...
    Parotitis features 5 subtypes, namely: (1) acute viral, (2) acute suppurative, (3) sialolithiasis-associated, (4) chronic non-neoplastic, and (5) chronic ...
  12. [12]
    parotitis, n. meanings, etymology and more | Oxford English Dictionary
    The earliest known use of the noun parotitis is in the late 1700s. OED's earliest evidence for parotitis is from 1796, in the writing of Erasmus Darwin, ...
  13. [13]
    Parotid - Etymology, Origin & Meaning
    Originating from Greek parotis meaning "tumor near the ear," via Latin and French, parotid refers to the gland or area situated beside the ear.
  14. [14]
    Chapter 9: Mumps | Manual for the Surveillance of Vaccine ... - CDC
    Jun 18, 2025 · Mumps is an acute viral illness caused by a paramyxovirus and typically presents as swelling of the parotid (parotitis) or other salivary gland.<|control11|><|separator|>
  15. [15]
    Sialolithiasis - StatPearls - NCBI Bookshelf - NIH
    Sialolithiasis is the most common benign cause of salivary gland swelling; however, it remains a relatively rare diagnosis with an incidence of 1 in 10,000 to 1 ...Missing: adults | Show results with:adults
  16. [16]
    Global childhood vaccination coverage holds steady, yet over 14 ...
    Jul 15, 2025 · Global childhood vaccination coverage holds steady, yet over 14 million infants remain unvaccinated – WHO, UNICEF · Access to vaccines remains ...Missing: mumps incidence
  17. [17]
    Parotitis Clinical Presentation: History, Physical, Causes
    Aug 13, 2024 · Acute viral parotitis (mumps): Pain and swelling of the gland last 5-9 days. Moderate malaise, anorexia, and fever occur. Bilateral involvement ...
  18. [18]
    Salivary Gland Problems: Identification, Causes & Treatment - WebMD
    Feb 10, 2025 · This condition causes a painful lump in the gland, and foul-tasting pus drains into the mouth. Sialadenitis is more common in older adults ...<|separator|>
  19. [19]
    Parotitis, Acute and Chronic | 5-Minute Clinical Consult
    Acute bacterial parotitis: dehydration, debilitation, poor oral hygiene ... Acute bacterial parotitis can be associated with leukocytosis and elevated ...
  20. [20]
    Suppurative Parotitis - Consultant360
    Acute bacterial parotitis is generally caused by Staphylococcus aureus ... This is associated with localized tenderness, fever, chills, marked toxicity, trismus, ...
  21. [21]
    acute bacterial infection of the salivary glands
    Treatment of viral salivary gland infection is primarily supportive, including rest and adequate hydration, because the disease is self-limited. Antipyretics ...Missing: leukocytosis | Show results with:leukocytosis
  22. [22]
    Salivary Gland Disorders - AAFP
    Jun 1, 2014 · Recurrent parotitis of childhood is an inflammatory condition of the parotid gland characterized by recurrent episodes of swelling and pain. ...Missing: progression | Show results with:progression
  23. [23]
    Chronic Parotitis: A Challenging Disease Entity - Sage Journals
    Chronic parotitis is a troubling clinical condition char- acterized by repeated infection and inflammation of the parotid gland caused by decreased salivary ...Missing: middle- sialectasia
  24. [24]
    Sjogren Syndrome - StatPearls - NCBI Bookshelf - NIH
    Jul 6, 2025 · Sjögren syndrome is a systemic autoimmune disease ... Extraglandular features may include dry skin, joint pain, fatigue, or symptoms affecting ...Sjogren Syndrome · History And Physical · ComplicationsMissing: parotitis | Show results with:parotitis
  25. [25]
    Acute bacterial suppurative parotitis: microbiology and management
    The most common pathogens associated with acute bacterial parotitis are Staphylococcus aureus and anaerobic bacteria. The predominant anaerobes include gram ...Missing: prevalence 70-90%
  26. [26]
    Mumps: resurgence of a vanquished virus - PMC - NIH
    The clinical hallmark of mumps is parotitis, which is bilateral in 70% of patients. When inhaled, the virus enters the upper respiratory tract, travels to local ...
  27. [27]
    Diagnosis and Management of Parotitis - JAMA Network
    Viral parotitis can be caused by paramyxovirus (mumps), Epstein-Barr virus, coxsackievirus, and influenza A and parainfluenza viruses. Acute suppurative ...
  28. [28]
    Candida Infection Associated with Salivary Gland—A Narrative ... - NIH
    Dec 30, 2020 · Mostly, salivary gland infection with Candida occurs in individuals with impaired immunity, including persons impacted by HIV/AIDS [55]. ...
  29. [29]
    [PDF] Suppurative Parotitis Due to Candida glabrata - DukeSpace
    10 Risk factors for oral colonization of C. glabrata are dentures, immunosuppression, antibiotic therapy, and aging.11 One of the major risk factors for both ...
  30. [30]
    Non-tuberculous mycobacterial infection of the parotid gland in ... - NIH
    Oct 16, 2013 · It was suggested that most NTM infections of the parotid gland are caused by Mycobacterium ascending via Stensen's duct in the oral cavity.
  31. [31]
    Parotid sialolithiasis - PMC - NIH
    Sialoliths, or salivary stones, are the most common disease of the salivary glands in middle-aged patients. More than 80% of salivary sialoliths occur in the ...
  32. [32]
    Recurrent Parotitis as a Presentation of Primary Pediatric Sjögren ...
    Jan 1, 2012 · Parotitis is encountered relatively frequently in the pediatric population. It is typically acute and self-limiting and usually represents viral ...
  33. [33]
    Chronic Parotitis in Primary Sjögren's Syndrome - PMC - NIH
    The patient was diagnosed with Sjögren's syndrome with acute exacerbation of chronic parotitis with multiple calcifications.
  34. [34]
    Sialadenitis | Radiology Reference Article - Radiopaedia.org
    Aug 27, 2025 · Other causes of acute sialadenitis include dehydration, immunosuppression, iatrogenic (drug-induced) and rarely hematogenous spread 10. Rarely ...
  35. [35]
    Juvenile recurrent parotitis - PMC - NIH
    It is a rare condition and characterized by multiple episodes of parotid swelling and/or pain associated with fever or malaise over a period of years.
  36. [36]
    Juvenile Recurrent Parotitis - Children's Hospital of Philadelphia
    Care is taken to distinguish between conditions that can have similar symptoms, such as salivary duct stones (sialoliths), salivary gland tumors, autoimmune ...
  37. [37]
    Salivary Swelling (Parotid and Submandibular Glands)
    May 20, 2017 · Differential Diagnosis. Obstructive Sialadenitis. Sialolithiasis ... Submandibular abscess can mimic Ludwig's angina. Viral Parotitis or ...
  38. [38]
    Bilateral parotid swelling: a radiological review - PMC
    The main differential diagnosis for this appearance is lymphoma. In the diffuse form, parotid glands are symmetrically enlarged and show increased signal ...<|control11|><|separator|>
  39. [39]
    Approach to sialadenitis - PMC - NIH
    Red flags such as suspected abscess formation, signs of respiratory obstruction, facial paresis, and fixation of a mass to underlying tissue should prompt ...
  40. [40]
    EM@3AM: Suppurative Parotitis - emDocs
    Jul 29, 2023 · Bacterial: Staph aureus is the most common bacterial cause. Other bacterial causes include anaerobic oral flora, Strep viridans, E. · Less common ...
  41. [41]
    Parotitis Workup: Laboratory Studies, Imaging Studies, Procedures
    Aug 13, 2024 · CT scanning and MRI with gadolinium enhancement. These studies may be used to determine the size, shape, and some qualities of neoplasms or ...Laboratory Studies · Imaging Studies · Procedures
  42. [42]
    Laboratory Testing for Mumps - CDC
    Jun 11, 2024 · Real-time RT-PCR is the preferred method to confirm mumps; it's more sensitive and specific than serologic assays to detect IgM. The successful ...
  43. [43]
  44. [44]
    Sequential quantitative scintigraphy of parotid glands with chronic ...
    Scintigraphy is considered to be a useful method for evaluation of parotid function and as a diagnostic aid for SS and COP, especially in patients in whom ...
  45. [45]
    Parotitis Treatment & Management - Medscape Reference
    Aug 13, 2024 · Acute bacterial parotitis is caused by bacteria that ascends from the mouth and most frequently occurs in chronically ill patients. The patient ...
  46. [46]
    Parotitis | Johns Hopkins ABX Guide
    Mar 16, 2025 · Acute parotitis: severe pain, tenderness, erythematous swelling--pre-auricular to the angle of the jaw, not necessarily infectious.Missing: prevalence | Show results with:prevalence
  47. [47]
    Salivary Gland Infection: Care Instructions
    Eat soft foods that do not have to be chewed much. Use sugar-free gum or candies such as lemon drops. They increase saliva. Avoid over-the-counter medicines ...
  48. [48]
    Parotitis: Care Instructions - MyHealth Alberta
    Parotitis is a swelling of your parotid glands. These are salivary glands located between the ear and jaw. The most common cause is a virus.
  49. [49]
    Parotitis: Care Instructions - Kaiser Permanente
    To prevent dehydration, drink plenty of fluids. If you have kidney, heart, or liver disease and have to limit fluids, talk with your doctor before you increase ...Missing: measures management
  50. [50]
    [PDF] Acute Infantile Suppurative Parotitis - Annals of Clinical Case Reports
    Nov 18, 2022 · Blood Smear: Leukocytosis - Neutrophilia and Monocytosis and Microcytic Anemia. Seen on the same day by the PICU team due to concerns on ...<|control11|><|separator|>
  51. [51]
    Parotitis, Acute and Chronic | 5-Minute Clinical Consult
    Antibiotic therapy for bacterial parotitis combined with adequate hydration should result in improvement within 48 hours; if not, patient should be reevaluated.
  52. [52]
    Acyclovir - StatPearls - NCBI Bookshelf - NIH
    Acyclovir is an agent used to treat infections caused by the herpes simplex virus (HSV). Acyclovir is FDA-approved to treat genital herpes and HSV encephalitis.
  53. [53]
    Ultrasound-Guided Needle Aspiration vs. Surgical Incision of Parotid ...
    Ultrasonography-guided needle aspiration of parotid abscess offers a less invasive alternative to surgical incision and drainage. A sonographic approach is ...
  54. [54]
    Sialendoscopy for the Management of Obstructive Salivary Gland ...
    Sialendoscopy offers a minimally invasive approach to disease management. This technique allows endoscopic intraluminal visualization and offers a mechanism to ...
  55. [55]
    A case of retention cyst of the parotid gland treated successfully by ...
    Intraoral marsupialization for retention cysts of the parotid gland is a minimally invasive method without the risk of skin scarring and facial nerve paralysis.
  56. [56]
    EULAR recommendations for the management of Sjögren's ...
    The recommendations address the use of topical oral (saliva substitutes) and ocular (artificial tear drops, topical non-steroidal anti-inflammatory drugs, ...
  57. [57]
    Rituximab Therapy for Primary Sjögren's Syndrome: An Open-Label ...
    The treatment of primary Sjögren's syndrome is largely based on alleviation of symptoms and includes the use of topical cyclosporine for management of dry eyes, ...Missing: parotitis | Show results with:parotitis
  58. [58]
    Treatment of Primary Sjögren Syndrome: A Systematic Review
    Jul 28, 2010 · Conclusions In primary Sjögren syndrome, evidence from controlled trials suggests benefits for pilocarpine and cevimeline for sicca features ...Missing: parotitis | Show results with:parotitis
  59. [59]
    Surgical Treatment of Chronic Parotitis - PMC - PubMed Central
    Oct 24, 2018 · This study shows parotidectomy to be a safe and effective treatment for chronic recurring parotitis. After failure of conservative therapy, 80% ...
  60. [60]
    Strategies for the Control and Investigation of Mumps Outbreaks - CDC
    Sep 20, 2024 · Suspected mumps patients should self-isolate for 5 days after onset of parotitis or other salivary gland swelling, even while lab results are ...